Imiquimod Cream 3.75%
This immune response modifier was approved for the topical treatment of multiple actinic keratoeses located on the face or balding scalp in adults.
Theravance Inc./Astellas Pharma
Approved as a once daily injectable antibiotic for the treatment of adults with complicated skin and skin structure infections caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant and methicillin-susceptible strains.
Johnson & Johnson
Approved for the palliative treatment of skin manifestations of cutaneous T-cell lymphoma (CTCL) unresponsive to other forms of treatment.
This histone deacetylase inhibitor was approved for the treatment of CTCL in patients who have received at least 1 prior systemic therapy.
Approved for the relief of symptoms from perennial allergic rhinitis and chronic idiopathic urticaria in children =6 months of age.
Approval was granted to this novel topical vitamin D3 agent for the treatment of mild-to-moderate plaque psoriasis in adults.
A new indication was granted to this biologic for the treatment of chronic severe plaque psoriasis in children aged =8 years.
Centocor Ortho Biotech/
This first-in-class human monoclonal antibody that selectively targets the cytokines interleukin-12 and interleukin-23 was approved for the treatment of moderate-to-severe plaque psoriasis in adults =18 years of age.
Acyclovir + Hydrocortisone Cream
This topical product combining an antiviral with an anti-inflammatory was approved for the prevention and treatment of recurrent herpes labialis. Indicated for adults and children =12 years of age.
Approval of this acetylcholine release inhibitor and neuromuscular blocking agent was granted for the temporary improvement in the appearance of moderate-to-severe glabellar lines in adults aged
Botulinum Toxin – Type A
This neurotoxin received approval for the temporary improvement in the appearance of moderate-to-severe glabellar lines in adult patients
Agence Française de Sécurité Sanitaire de Produits de Santé (France)
Collagen-based Dermal Filler
A labeling supplement was approved, that includes efficacy and safety data through 12 months, for this collagen-based dermal filler for the correction of moderate to deep facial wrinkles and folds.
Injectable Poly-L-lactic Acid
Approved for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles.
Approved as a once daily oral retinoid treatment for adults with severe chronic hand eczema refractory to potent topical corticosteroids.
This antiretroviral agent was approved for the treatment of HIV infection to be used once daily in treatment-naïve adults in combination with other antiretroviral agents, such as ritonavir.
Approved for use in treatment-experienced adults who are encountering virologic failure with HIV-1 strains resistant to a non-nucleoside reverse transcriptase inhibitor and other antiretroviral agents.
Benzyl Alcohol Lotion 5%
This new prescription non-neurotoxic medication was approved for the treatment of head lice in patients =6 months of age.
Capsaicin 8% Transdermal Patch
Approved for the management of neuropathic pain due to postherpetic neuralgia. This medicated skin patch can provide up to 12 weeks of pain reduction following a single 1-hour application.
Centocor Ortho Biotech/
This once monthly, subcutaneous, anti-TNF-a human monoclonal antibody was approved for the treatment of moderate-to-severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Human Papillomavirus Bivalent
Approved for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18; for use in girls and women aged 10-25 years.
Human Papillomavirus Quadrivalent
Merck & Co.
Approved for use in boys and men 9-26 years of age for the prevention of genital warts caused by HPV types 6 and 11.
Oculus Innovative Sciences
Clearance was given to market this product (both as a prescription and an OTC formulation) for the management of exuding wounds (e.g., leg ulcers, pressure ulcers, and diabetic ulcers) and for the management of mechanically or surgically debrided wounds.
Estradiol Vaginal Tablet
Approved for the treatment of atrophic vaginitis due to menopause.